RemedyRepack Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection OAI · Apr 14, 2025
  • 1 Class I recall
  • Last warning letter 2023
Inspections 6 2 OAI
Recalls 61 1 Class I (2%)
Warning letters 2 Latest May 11, 2023
510(k) clearances 0 None on file

RemedyRepack Inc. has 61 FDA recalls (1 Class I), 6 inspections, 0 510(k) clearances and 2 compliance actions on record. FDA has issued 2 warning letters to RemedyRepack Inc., the most recent on May 11, 2023.

What these totals cover: FDA records filed under the name "RemedyRepack Inc." and its spelling variant "Remedyrepack".

Latest recall
D-0411-2025 · Class II · Apr 22, 2025
Latest inspection
Apr 14, 2025 · OAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls61 (1 Class I)Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections6Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions2Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

RemedyRepack Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

RemedyRepack Inc.: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 9 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 5 recall records (1 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2022: 1 inspection (1 OAI), 0 warning letters, 7 recall records (0 Class I) 2023: 0 inspections (0 OAI), 1 warning letter, 17 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 4 recall records (0 Class I) 2025: 1 inspection (1 OAI), 0 warning letters, 3 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202511030
202400040
2023001170
202211070
202100030
202000020
201900051
201810090
201700020

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing RemedyRepack Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check RemedyRepack Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

RemedyRepack Inc. FDA Warning Letters

2 warning letters from Mar 31, 2015 to May 11, 2023.

IssuedSubjectIssuing officeClose-out letter
May 11, 2023 · Letter on fda.gov CGMP/Finished Pharmaceuticals/AdulteratedDivision of Pharmaceutical Quality Operations I
Mar 31, 2015 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

61 recall records from Feb 18, 2015 to Apr 22, 2025. Showing the 20 most recent. View all 61 recall records

NumberClassProductDate
D-0411-2025Class IIClindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack…Apr 22, 2025
D-0378-2025Class IIClindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack…Mar 24, 2025
D-0217-2025Class IICarvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by…Jan 24, 2025
D-0165-2025Class IIDuloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30…Dec 2, 2024
D-0611-2024Class IIPotassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules, 30-count blister card, Rx only…Jun 26, 2024
D-0549-2024Class IIPhenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc…May 31, 2024
D-0489-2024Class IITraMADol HCl 50 mg Tablet, Packaged as (a) 30-count blister pack, NDC 70518-3824-00; (b) 90-count…May 2, 2024
D-0577-2023Class IIKetotifen Fumarate 0.025 %, Antihistamine eye drops, 5mL bottle, MFG: Akorn, Lake Forrest IL 60045…May 1, 2023
D-0578-2023Class IIPyrazinamide, 500 mg Tablet, packaged in a) 29 x 30-count card, NDC # 70518-2534-01; b) 1 x 100 UD…May 1, 2023
D-0576-2023Class IILORazepam Injection, 2mg / mL Single Dose vial 1ml vial, Rx Only, MFG Akorn Lake Forest IL 60045…May 1, 2023
D-0493-2023Class IIGlimepiride 2 mg tablets, packaged in a) 30-count bottles (NDC 70518-0405-03), b) 90-count bottles…Mar 20, 2023
D-0503-2023Class IISimvastatin 40 mg tablets, packaged in a) 30-count bottles (NDC 70518-0060-01) and b) 90-count…Mar 20, 2023
D-0496-2023Class IISimvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-0064-01) and b) 90-count…Mar 20, 2023
D-0492-2023Class IIDoxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC…Mar 20, 2023
D-0490-2023Class IIAripiprazole 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA…Mar 20, 2023
D-0495-2023Class IIRosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA…Mar 20, 2023
D-0500-2023Class IIRosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA…Mar 20, 2023
D-0491-2023Class IIAtorvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-1946-00) and b) 90-count…Mar 20, 2023
D-0494-2023Class IIRopinirole 0.5 mg tablets, packaged in 90-count bottles, Rx only, Repackaged by: RemedyRepack Inc…Mar 20, 2023
D-0499-2023Class IIRopinirole 2mg tablets, packaged in 180-count bottles, Rx only, Repackaged by: RemedyRepack Inc…Mar 20, 2023

Recent FDA inspections

6 inspections from May 28, 2009 to Apr 14, 2025.

DateSiteProductClassificationFEI
Apr 14, 2025Indiana, PADrugsOfficial Action Indicated (OAI)3005841768
Nov 10, 2022Indiana, PADrugsOfficial Action Indicated (OAI)3005841768
Mar 30, 2018Indiana, PADrugsVoluntary Action Indicated (VAI)3005841768
Nov 23, 2015Indiana, PADrugsVoluntary Action Indicated (VAI)3005841768
May 16, 2011Indiana, PADrugsVoluntary Action Indicated (VAI)3005841768
May 28, 2009Indiana, PADrugsVoluntary Action Indicated (VAI)3005841768
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 2 compliance actions under RemedyRepack Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, May 11, 2023.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3005841768Indiana, PA6Apr 14, 2025

RemedyRepack Inc. and the FDA: common questions

Has RemedyRepack Inc. received an FDA warning letter?

Yes. FDA has issued 2 warning letters to RemedyRepack Inc.. The most recent is dated May 11, 2023, with the subject "CGMP/Finished Pharmaceuticals/Adulterated".

Has RemedyRepack Inc. received an FDA Form 483?

FDA has not published a Form 483 for "RemedyRepack Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect RemedyRepack Inc.?

The most recent FDA inspection on file ended Apr 14, 2025 at Indiana, PA and was classified OAI. FDA has 6 inspections of RemedyRepack Inc. on file, 2 of them classified OAI (official action indicated).

Has RemedyRepack Inc. had an FDA recall?

Yes. RemedyRepack Inc. has 61 FDA recalls on record, 1 of them Class I, the most serious class. The most recent started Apr 22, 2025.

Need more than this page shows? Ask about RemedyRepack Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.